Manher (AJ) Joshi, MD

Manher (AJ) Joshi was appointed to the role of Atara Biotherapeutics’ chief medical officer in September 2018. He joined Atara in August 2016, initially serving as senior vice president, global medical affairs. He brings more than 15 years of clinical, drug development, and commercialization experience in orphan and large markets to his role at Atara. AJ has built and led medical organizations through several launches across a broad range of therapeutics areas, including neuromuscular disease, neurosciences, genetics, metabolic diseases, urology, and dermatology. His previous organizational leadership roles include us medical affairs therapeutic area head at Allergan, SVP strategic development and medical operations at Synageva, and vice president medical affairs and operations at Genzyme. AJ received his MD from the Boston University School of Medicine, his BA from Boston University, and completed his internship and residency in medicine at Yale.